NOVTNovanta Inc.
146.69USD+0.51%Mkt Cap: 5.52B $P/E: 91.79

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internatio…

Key Statistics

Company
Market Cap5.52B $
Enterprise Value5.07B $
Revenue (TTM)1.03B $
Gross Profit435.28M $
Net Income (TTM)53.83M $
Revenue/Share26.45 USD
Last Price146.69 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees3.0K
CountryUS
SectorTechnology
IndustryScientific & Technical Instruments
ISIN
Valuation
P/E (Trailing)91.79
P/E (Forward)33.33
PEG
EV/EBITDA28.02
EV/Revenue4.92
P/S5.34
P/B3.40
EPS (TTM)1.57
EPS (Forward)4.37
52W Range
98.2762% of range176.19
52W High176.19 USD
52W Low98.27 USD
Profitability
Gross Margin44.39%
Oper. Margin11.50%
EBITDA Margin17.57%
Profit Margin5.49%
ROE4.10%
ROA2.98%
Growth
Revenue Growth10.30%
Earnings Growth150.00%
Cash Flow & Leverage
Operating CF64.06M $
CapEx (TTM)15.63M $
FCF Margin11.50%
FCF Yield2.14%
Net Debt-433.05M $
Net Debt/EBITDA-2.39
Balance Sheet
Debt/Equity0.23
Current Ratio4.57
Quick Ratio3.65
Book Value/Sh42.74 USD
Cash/Share19.00 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:3
Split DateDec 29, 2010
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)194.50 USD
Upside (mean)+32.6%
Target Range194.00 USD195.00 USD
$194.00+32.6% to mean$195.00
# Analysts2
Ownership
Shares Out.37.82M
Float37.54M
Insiders0.71%
Institutions123.54%
Short Interest
Short Ratio10.8d
Short % Float15.68%
Short % Out.13.65%
Shares Short5.16M
Short (prev mo.)5.25M
Technical
SMA 50153.82 (-4.6%)
SMA 200135.91 (+7.9%)
Beta1.68
S&P 52W Chg18.16%
Avg Vol (30d)445.94K
Avg Vol (10d)350.12K
Technical Indicators
RSI (14)41.9
MACD3.2466
MACD Signal2.8187
MACD Hist.+0.4279
BB Upper177.16 USD
BB Middle153.47 USD
BB Lower129.78 USD
BB Width30.87%
ATR (14)8.207 USD
Vol Ratio (20d)1.05x